Cue Health completes $45MM Series B financing

Cue Health Inc. (“Cue”), a healthcare technology company developing a range of diagnostic products for professionals and consumers, announced that it has raised over $45M in Series B financing. The financing will be used to complete development and fund the initial set of FDA 510(k) clinical studies for Cue’s first set of diagnostic products. New investors in the round are Johnson & Johnson Innovation – JJDC, Inc., Section 32, Dentsu Ventures, Synergy Ventures, Principles of Tarsadia Investments, Pritzker Group Venture Capital, Troy Capital, and Babel Ventures. Returning investors include Sherpa Capital, Cove Investments, and Rohan Oza.